SCL and LMO1 alter thymocyte differentiation: inhibition of E2A-HEB function and pre-T alpha chain expression - PubMed (original) (raw)

SCL and LMO1 alter thymocyte differentiation: inhibition of E2A-HEB function and pre-T alpha chain expression

S Herblot et al. Nat Immunol. 2000 Aug.

Abstract

Cooperation between the stem cell leukemia (SCL) transcription factor and its nuclear partners LMO1 or LMO2 induces aggressive T cell acute lymphoblastic leukemia when inappropriately expressed in T cells. This study examined the cellular and molecular targets of the SCL-LMO complex at the preleukemic stage. We show that SCL and its partners are coexpressed in the most primitive thymocytes. Maturation to the pre-T cell stage is associated with a down-regulation of SCL and LMO1 and LMO2, and a concomitant up-regulation of E2A and HEB expression. Moreover, enforced expression of SCL-LMO1 inhibits T cell differentiation and recapitulates a loss of HEB function, causing a deregulation of the transition checkpoint from the CD4-CD8- to CD4+CD8+ stages. Finally, we identify the gene encoding pT alpha as a downstream target of HEB that is specifically repressed by the SCL-LMO complex.

PubMed Disclaimer

Comment in

Intertwining proteins in thymocyte development and cancer.
Murre C. Murre C. Nat Immunol. 2000 Aug;1(2):97-8. doi: 10.1038/77881. Nat Immunol. 2000. PMID: 11248796 Review. No abstract available.

Cited by

Therapy with the histone deacetylase inhibitor pracinostat for patients with myelofibrosis.
Quintás-Cardama A, Kantarjian H, Estrov Z, Borthakur G, Cortes J, Verstovsek S. Quintás-Cardama A, et al. Leuk Res. 2012 Sep;36(9):1124-7. doi: 10.1016/j.leukres.2012.03.003. Epub 2012 Apr 2. Leuk Res. 2012. PMID: 22475363 Free PMC article. Clinical Trial.
p16INK4A tumor suppressor gene expression and CD3epsilon deficiency but not pre-TCR deficiency inhibit TAL1-linked T-lineage leukemogenesis.
Fasseu M, Aplan PD, Chopin M, Boissel N, Bories JC, Soulier J, von Boehmer H, Sigaux F, Regnault A. Fasseu M, et al. Blood. 2007 Oct 1;110(7):2610-9. doi: 10.1182/blood-2007-01-066209. Epub 2007 May 16. Blood. 2007. PMID: 17507663 Free PMC article.
Modeling T-cell acute lymphoblastic leukemia induced by the SCL and LMO1 oncogenes.
Tremblay M, Tremblay CS, Herblot S, Aplan PD, Hébert J, Perreault C, Hoang T. Tremblay M, et al. Genes Dev. 2010 Jun 1;24(11):1093-105. doi: 10.1101/gad.1897910. Genes Dev. 2010. PMID: 20516195 Free PMC article.
The upstream enhancer is necessary and sufficient for the expression of the pre-T cell receptor alpha gene in immature T lymphocytes.
Reizis B, Leder P. Reizis B, et al. J Exp Med. 2001 Oct 1;194(7):979-90. doi: 10.1084/jem.194.7.979. J Exp Med. 2001. PMID: 11581319 Free PMC article.
LMO2 activation by deacetylation is indispensable for hematopoiesis and T-ALL leukemogenesis.
Morishima T, Krahl AC, Nasri M, Xu Y, Aghaallaei N, Findik B, Klimiankou M, Ritter M, Hartmann MD, Gloeckner CJ, Stefanczyk S, Lindner C, Oswald B, Bernhard R, Hähnel K, Hermanutz-Klein U, Ebinger M, Handgretinger R, Casadei N, Welte K, Andre M, Müller P, Bajoghli B, Skokowa J. Morishima T, et al. Blood. 2019 Oct 3;134(14):1159-1175. doi: 10.1182/blood.2019000095. Epub 2019 Jul 31. Blood. 2019. PMID: 31366618 Free PMC article.

SCL and LMO1 alter thymocyte differentiation: inhibition of E2A-HEB function and pre-T alpha chain expression - PubMed (original) (raw)